Hypoglycemia in patients with type 2 diabetes newly initiated on basal insulin in the US in a community setting: impact on treatment discontinuation and hospitalization
1. Employee of Sanofi US at the time of the study;2. Millennium Pharmaceuticals Inc., Cambridge, MA, USA;3. Abbott Diabetes Care, Alameda, CA, USA;4. Techdata Service LLC, King of Prussia, PA, USA